Vitrolife AB Stock OTC Markets

Equities

VTRLY

US92852Y1010

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets 03:13:11 2023-11-01 pm EDT 5-day change 1st Jan Change
13.3 USD +16.16% Intraday chart for Vitrolife AB -.--% -.--%
Sales 2024 * 3.65B 347M Sales 2025 * 3.97B 377M Capitalization 23.68B 2.25B
Net income 2024 * 565M 53.69M Net income 2025 * 675M 64.14M EV / Sales 2024 * 6.65 x
Net Debt 2024 * 587M 55.74M Net cash position 2025 * 128M 12.14M EV / Sales 2025 * 5.93 x
P/E ratio 2024 *
41.9 x
P/E ratio 2025 *
35.1 x
Employees 1,132
Yield 2024 *
0.68%
Yield 2025 *
0.79%
Free-Float 55.35%
More Fundamentals * Assessed data
Dynamic Chart
1 year
11.45
Extreme 11.45
21.49
3 years
11.45
Extreme 11.45
59.29
5 years
11.45
Extreme 11.45
59.29
10 years
11.45
Extreme 11.45
59.29
More quotes
Managers TitleAgeSince
Chief Executive Officer - 23-07-31
Director of Finance/CFO 54 21-12-31
Chairman 68 15-05-06
Members of the board TitleAgeSince
Director/Board Member 53 19-05-01
Chairman 68 15-05-06
Director/Board Member 64 18-04-26
More insiders
Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. It also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The Company is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
174.9 SEK
Average target price
231.7 SEK
Spread / Average Target
+32.46%
Consensus